Assessing the contribution of inflammation in models of Alzheimer's disease.
暂无分享,去创建一个
[1] D. Mann,et al. Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease , 2002, Neuroscience Letters.
[2] S. Hickman,et al. Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice , 2008, The Journal of Neuroscience.
[3] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[4] L. V. Van Eldik,et al. Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid , 2005, Journal of Neuroinflammation.
[5] N. Rothwell,et al. Inflammation in central nervous system injury. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[6] D. Morgan,et al. Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice , 2004, Experimental Neurology.
[7] N. Zilka,et al. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease , 2010, Journal of Neuroinflammation.
[8] J. Relton,et al. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. , 2008, Brain : a journal of neurology.
[9] N. Robakis,et al. It May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease , 2007, Neurodegenerative Diseases.
[10] P. Zandi,et al. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence. , 2010, CNS & neurological disorders drug targets.
[11] Henrik Zetterberg,et al. Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.
[12] M. Szyf,et al. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.
[13] V. Perry,et al. Systemic inflammation and disease progression in Alzheimer disease , 2009, Neurology.
[14] D. Wilcock,et al. Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics , 2005, Journal of neuropathology and experimental neurology.
[15] Ying-Dong Zhang,et al. Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains , 2011, Brain Research.
[16] D. Brooks,et al. Inflammatory risk factors and pathologies associated with Alzheimer's disease. , 2011, Current Alzheimer Research.
[17] H. Kettenmann,et al. Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.
[18] Inbal Goshen,et al. Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.
[19] K. Zahs,et al. ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? , 2010, Trends in Neurosciences.
[20] D. Morgan,et al. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice , 2010, Journal of Neuroinflammation.
[21] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[22] J. Götz,et al. Animal models for Alzheimer's disease and frontotemporal dementia: a perspective , 2009, ASN neuro.
[23] R. Mrak,et al. Interleukin‐1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease , 2002, Journal of leukocyte biology.
[24] Jae Woong Lee,et al. Journal of Neuroinflammation Neuro-inflammation Induced by Lipopolysaccharide Causes Cognitive Impairment through Enhancement of Beta-amyloid Generation , 2022 .
[25] C. Heyser,et al. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. O’Banion,et al. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective , 2008, Journal of Neuroinflammation.
[27] D. Dickson,et al. Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] Seth Love,et al. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.
[29] Michael J Owen,et al. Alzheimer's disease genetics: current knowledge and future challenges , 2011, International journal of geriatric psychiatry.
[30] Michal Schwartz,et al. Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model , 2007, The European journal of neuroscience.
[31] S. Lockett,et al. Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid β Peptide* , 2006, Journal of Biological Chemistry.
[32] M. Fornerod,et al. Characterization of the Drosophila melanogaster genome at the nuclear lamina , 2006, Nature Genetics.
[33] D. Dickson,et al. IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice , 2010, The Journal of Immunology.
[34] M. O’Banion,et al. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. , 2007, The Journal of clinical investigation.
[35] F. LaFerla,et al. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. , 2008, The American journal of pathology.
[36] S. Rivest,et al. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease , 2006, Molecular Psychiatry.
[37] Jeffrey A. James,et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.
[38] James L. Buescher,et al. Interferon-and Tumor Necrosis Factor-Regulate Amyloid-Plaque Deposition and-Secretase Expression in Swedish Mutant APP Transgenic Mice , 2007 .
[39] J. Julien,et al. Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.
[40] H. Braak,et al. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.
[41] S. C.A.,et al. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence. , 2010 .
[42] N. Rothwell,et al. Interleukin-1 and neuronal injury , 2005, Nature Reviews Immunology.
[43] M. Tansey,et al. Molecular Neurodegeneration BioMed Central Review , 2009 .
[44] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[45] R. Ransohoff,et al. Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.
[46] Colm Cunningham,et al. Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.
[47] Tetsuya Suhara,et al. Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography , 2007, The Journal of Neuroscience.
[48] R. Ransohoff,et al. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. , 2010, The American journal of pathology.
[49] M. O’Banion,et al. Neuroinflammatory processes in Alzheimer’s disease , 2010, Journal of Neural Transmission.
[50] F. LaFerla,et al. Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.